HU9403184D0 - Isoquinolines - Google Patents
IsoquinolinesInfo
- Publication number
- HU9403184D0 HU9403184D0 HU9403184A HU9403184A HU9403184D0 HU 9403184 D0 HU9403184 D0 HU 9403184D0 HU 9403184 A HU9403184 A HU 9403184A HU 9403184 A HU9403184 A HU 9403184A HU 9403184 D0 HU9403184 D0 HU 9403184D0
- Authority
- HU
- Hungary
- Prior art keywords
- isoquinolines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939322828A GB9322828D0 (en) | 1993-11-05 | 1993-11-05 | Organic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9403184D0 true HU9403184D0 (en) | 1994-12-28 |
| HUT71350A HUT71350A (en) | 1995-11-28 |
| HU217120B HU217120B (hu) | 1999-11-29 |
Family
ID=10744697
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9403184A HU217120B (hu) | 1993-11-05 | 1994-11-04 | A IV. típusú PDE-izoenzimek működését gátló izokinolinszármazékok |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US5747506A (hu) |
| EP (1) | EP0664289A3 (hu) |
| JP (1) | JPH07188176A (hu) |
| KR (1) | KR950014073A (hu) |
| CN (1) | CN1051998C (hu) |
| AT (1) | AT404940B (hu) |
| AU (1) | AU685852B2 (hu) |
| CA (1) | CA2135000A1 (hu) |
| CH (1) | CH688478A5 (hu) |
| CZ (1) | CZ282329B6 (hu) |
| DE (1) | DE4438737A1 (hu) |
| FI (1) | FI945191A (hu) |
| FR (1) | FR2711989B1 (hu) |
| GB (2) | GB9322828D0 (hu) |
| HK (1) | HK1005776A1 (hu) |
| HU (1) | HU217120B (hu) |
| IL (1) | IL111518A (hu) |
| IT (1) | IT1273993B (hu) |
| NO (1) | NO302293B1 (hu) |
| NZ (1) | NZ264851A (hu) |
| PE (1) | PE30395A1 (hu) |
| PL (1) | PL178210B1 (hu) |
| RU (1) | RU2144027C1 (hu) |
| SK (1) | SK280298B6 (hu) |
| TW (1) | TW353067B (hu) |
| ZA (1) | ZA948738B (hu) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9312853D0 (en) | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
| US5591776A (en) | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
| US5922751A (en) | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
| US6166041A (en) | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
| US6075016A (en) | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
| ID19155A (id) * | 1996-12-13 | 1998-06-18 | Tanabe Seiyaku Co | Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya |
| US5919794A (en) * | 1998-05-11 | 1999-07-06 | Virginia Commonwealth University | Methods of using pharmaceutical tetrahydroisoquinolines |
| US6200771B1 (en) * | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
| IL132407A0 (en) * | 1998-10-21 | 2001-03-19 | Pfizer Prod Inc | Method for treating congestive heart failure |
| DE19930614A1 (de) * | 1999-07-02 | 2001-01-04 | Mann & Hummel Filter | Filtereinsatz |
| DE60043318D1 (de) | 1999-08-21 | 2010-01-14 | Nycomed Gmbh | Synergistische kombination von pumafentrine und salmeterol |
| JP2003526677A (ja) * | 2000-03-14 | 2003-09-09 | ザ・ユニバーシテイ・オブ・ウエスタン・オンタリオ | 骨形成に影響を与える組成物および方法 |
| AU2002224835A1 (en) * | 2000-11-14 | 2002-05-27 | Byk Gulden Lomberg Chemische Fabrik G.M.B.H. | Dihydroisoquinolines as novel phosphodiesterase inhibitors |
| JP2004513938A (ja) | 2000-11-14 | 2004-05-13 | アルタナ ファルマ アクチエンゲゼルシャフト | ホスホジエステラーゼ阻害剤としての（ジヒドロ）イソキノリン誘導体 |
| DE10229762A1 (de) * | 2002-07-03 | 2004-01-22 | Aventis Pharma Deutschland Gmbh | Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| KR20050115331A (ko) | 2003-04-01 | 2005-12-07 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | 불임증 포스포디에스터라제의 억제제 |
| US7795385B2 (en) * | 2004-12-17 | 2010-09-14 | Bexar Global, Inc. | Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| JP5312466B2 (ja) * | 2008-10-02 | 2013-10-09 | 旭化成ファーマ株式会社 | ８位置換イソキノリン誘導体及びその用途 |
| KR20110071014A (ko) | 2008-10-17 | 2011-06-27 | 위스콘신 얼럼나이 리서어치 화운데이션 | 생물학적으로 활성인 알파-베타 펩티드의 제조 방법 |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| US9580471B2 (en) | 2011-03-01 | 2017-02-28 | Synergy Pharmaceuticals, Inc. | Process of preparing guanylate cyclase C agonists |
| US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法 |
| JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス，インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
| WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB645139A (en) * | 1946-10-22 | 1950-10-25 | Servita Gyogyszeryar Es Vegyip | Improved process for the production of isoquinoline derivatives |
| GB1400425A (en) * | 1971-09-22 | 1975-07-16 | Rolland Sa A | Substituted 3-hydroxymethyl-isoquinolines and derivatives |
| US3878215A (en) * | 1971-12-01 | 1975-04-15 | Sandoz Ag | 2-Alkyl-3-substituted-4-aryl isoquinolines |
| US4018927A (en) * | 1973-12-17 | 1977-04-19 | The Regents Of The University Of Michigan | Treatment of proliferating skin diseases with papaverine alkaloids |
| KR840002104B1 (ko) * | 1980-08-08 | 1984-11-15 | 부자 앙드레 | 신규 이소퀴놀린 유도체의 제법 |
| HU183479B (en) * | 1981-06-16 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing new 6,7-diethoxy-1-aracket-4-ethoxy-3-hydroxy-benzyl-bracket closed-3,4-dihydroisoquinolin |
| DE3244594A1 (de) * | 1982-12-02 | 1984-06-07 | Hoechst Ag, 6230 Frankfurt | 1-phenylisochinolinderivate und verfahren zu ihrer herstellung, diese verbindung enthaltende pharmazeutische praeparate und deren anwendung |
| GB8328052D0 (en) * | 1983-10-20 | 1983-11-23 | Beecham Group Plc | Compounds |
| US4761403A (en) * | 1986-04-09 | 1988-08-02 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
| HU196758B (en) * | 1986-05-21 | 1989-01-30 | Gyogyszerkutato Intezet | Process for production of 3-hidroxi-methil-quinolines and medical compositions containing them |
| PH25651A (en) * | 1986-05-21 | 1991-08-21 | Duphar Int Res | New di, tetrahydroisoquinoline derivatives |
| GB8800397D0 (en) * | 1988-01-08 | 1988-02-10 | Sandoz Ltd | Improvements in/relating to organic compounds |
| GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
-
1993
- 1993-11-05 GB GB939322828A patent/GB9322828D0/en active Pending
-
1994
- 1994-10-28 CH CH03226/94A patent/CH688478A5/de not_active IP Right Cessation
- 1994-10-28 FR FR9413108A patent/FR2711989B1/fr not_active Expired - Fee Related
- 1994-10-29 DE DE4438737A patent/DE4438737A1/de not_active Withdrawn
- 1994-11-01 EP EP94810628A patent/EP0664289A3/en not_active Withdrawn
- 1994-11-01 GB GB9421985A patent/GB2283488B/en not_active Expired - Fee Related
- 1994-11-03 FI FI945191A patent/FI945191A/fi unknown
- 1994-11-03 CZ CZ942698A patent/CZ282329B6/cs not_active IP Right Cessation
- 1994-11-03 NO NO944187A patent/NO302293B1/no not_active IP Right Cessation
- 1994-11-03 KR KR1019940028732A patent/KR950014073A/ko not_active Application Discontinuation
- 1994-11-03 IL IL11151894A patent/IL111518A/xx active IP Right Grant
- 1994-11-03 PE PE1994254101A patent/PE30395A1/es not_active Application Discontinuation
- 1994-11-03 SK SK1319-94A patent/SK280298B6/sk unknown
- 1994-11-03 NZ NZ264851A patent/NZ264851A/en unknown
- 1994-11-03 AU AU77610/94A patent/AU685852B2/en not_active Ceased
- 1994-11-03 CA CA002135000A patent/CA2135000A1/en not_active Abandoned
- 1994-11-03 IT ITRM940706A patent/IT1273993B/it active IP Right Grant
- 1994-11-04 CN CN94118199A patent/CN1051998C/zh not_active Expired - Fee Related
- 1994-11-04 ZA ZA948738A patent/ZA948738B/xx unknown
- 1994-11-04 AT AT0204894A patent/AT404940B/de not_active IP Right Cessation
- 1994-11-04 RU RU94040170A patent/RU2144027C1/ru active
- 1994-11-04 JP JP6271172A patent/JPH07188176A/ja active Pending
- 1994-11-04 PL PL94305705A patent/PL178210B1/pl unknown
- 1994-11-04 HU HU9403184A patent/HU217120B/hu not_active IP Right Cessation
- 1994-11-16 TW TW083110617A patent/TW353067B/zh active
-
1996
- 1996-12-20 US US08/771,556 patent/US5747506A/en not_active Expired - Lifetime
-
1998
- 1998-06-03 HK HK98104801A patent/HK1005776A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2283488B (en) | Isoquinolines | |
| DE69433664D1 (en) | Foetal-sensor | |
| DE69400639D1 (en) | Rehydratationsgetraenk | |
| DE69426415D1 (en) | Intrapulmonares hormonabgabesystem | |
| DE69421914D1 (en) | Ekg-sensor | |
| DE69401926D1 (en) | Hydroxamsäurederivate | |
| DE69406448D1 (en) | Luftreinigungsgerät | |
| DE69405713D1 (en) | Carbonylierungsverfahren | |
| DE69412242D1 (en) | Orthopädisches gussmaterial | |
| DE59407177D1 (en) | 2-fluorcycloyhexen-derivate | |
| DE69423875D1 (en) | Hydrodealkylierungsverfahren | |
| DE69429512D1 (en) | Thermoresistente alpha-1-antitrypsinmütante | |
| DE59409705D1 (en) | 3-methoxy-2-phenyl-acrylsäuremethylester | |
| DE59408644D1 (en) | Jacquardmaschine | |
| DE69408437D1 (en) | Oxychlorierungsverfahren | |
| GB2274735B (en) | Membraphone | |
| EP0730584A4 (en) | 3-ACYLAMINOBENZODIAZEPINE | |
| DE59408733D1 (en) | Metallhalogenidentladungslampe | |
| DE59410065D1 (en) | 3-methoxy-2-phenyl-acrylsäuremethylester | |
| DE69407946D1 (en) | Oxychlorierungskatalysator | |
| DE69412128D1 (en) | Kühlcontainer | |
| DE69425743D1 (en) | Faserreaktive anthrachinon-farbstoffe | |
| GB2274048B (en) | Headcollars | |
| DE69410761D1 (en) | Polyacetalharzzusammensetzung | |
| DE69422299D1 (en) | Photographisches reproduktionsgerät |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DGB9 | Succession in title of applicant |
Owner name: NOVARTIS AG., CH |
|
| HMM4 | Cancellation of final prot. due to non-payment of fee |